| Network model of survival signaling in large granular lymphocyte leukemia R Zhang, MV Shah, J Yang, SB Nyland, X Liu, JK Yun, R Albert, ... Proceedings of the National Academy of Sciences 105 (42), 16308-16313, 2008 | 449 | 2008 |
| Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease G Goyal, A Ravindran, JR Young, MV Shah, NN Bennani, MM Patnaik, ... Haematologica 105 (2), 348, 2019 | 172 | 2019 |
| Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes MV Shah, R Zhang, R Irby, R Kothapalli, X Liu, T Arrington, B Frank, ... Blood, The Journal of the American Society of Hematology 112 (3), 770-781, 2008 | 139 | 2008 |
| The Mayo Clinic Histiocytosis Working Group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease … G Goyal, JR Young, MJ Koster, WO Tobin, R Vassallo, JH Ryu, ... Mayo Clinic Proceedings 94 (10), 2054-2071, 2019 | 123 | 2019 |
| Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients E Morsia, K McCullough, M Joshi, J Cook, HB Alkhateeb, A Al‐Kali, ... American journal of hematology 95 (12), 1511-1521, 2020 | 114 | 2020 |
| NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human J Yu, T Mitsui, M Wei, H Mao, JP Butchar, MV Shah, J Zhang, A Mishra, ... The Journal of clinical investigation 121 (4), 1456-1470, 2011 | 100 | 2011 |
| The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders R Zhang, MV Shah, TP Loughran Jr Hematological oncology 28 (3), 105-117, 2010 | 100 | 2010 |
| Haploidentical transplantation for older patients with acute myeloid leukemia and myelodysplastic syndrome SO Ciurea, MV Shah, RM Saliba, S Gaballa, P Kongtim, G Rondon, ... Biology of blood and marrow transplantation 24 (6), 1232-1236, 2018 | 89 | 2018 |
| Acid ceramidase is upregulated in AML and represents a novel therapeutic target SF Tan, X Liu, TE Fox, BM Barth, A Sharma, SD Turner, A Awwad, ... Oncotarget 7 (50), 83208, 2016 | 89 | 2016 |
| Change in Pattern of HER2 Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory … MV Shah, AE Wiktor, RG Meyer, KS Tenner, KV Ballman, SJ Green, ... Journal of Clinical Oncology 34 (29), 3502-3510, 2016 | 79 | 2016 |
| A population-based study of large granular lymphocyte leukemia MV Shah, CC Hook, TG Call, RS Go Blood Cancer Journal 6 (e455), 2016 | 74 | 2016 |
| Early post-transplant minimal residual disease assessment improves risk stratification in acute myeloid leukemia MV Shah, JL Jorgensen, RM Saliba, SA Wang, AM Alousi, BS Andersson, ... Biology of Blood and Marrow Transplantation 24 (7), 1514-1520, 2018 | 73 | 2018 |
| Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long‐term outcomes. G Goyal, MV Shah, CC Hook, AP Wolanskyj, TG Call, KL Rech, RS Go British journal of haematology 182 (4), 2018 | 72 | 2018 |
| Clinical and radiologic responses to cladribine for the treatment of Erdheim-Chester disease G Goyal, MV Shah, TG Call, MR Litzow, WJ Hogan, RS Go JAMA oncology 3 (9), 1253-1256, 2017 | 68 | 2017 |
| Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia ZS Hasanali, BS Saroya, A Stuart, S Shimko, J Evans, MV Shah, ... Science translational medicine 7 (293), 293ra102-293ra102, 2015 | 63 | 2015 |
| Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia A Liao, K Broeg, T Fox, SF Tan, R Watters, MV Shah, LQ Zhang, Y Li, ... Blood, The Journal of the American Society of Hematology 118 (10), 2793-2800, 2011 | 54 | 2011 |
| Genetic and genomic landscape of secondary and therapy-related acute myeloid leukemia A Higgins, MV Shah Genes 11 (7), 749, 2020 | 50 | 2020 |
| Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms HB Alkhateeb, A Nanaa, D Viswanatha, JM Foran, T Badar, L Sproat, ... Blood advances 6 (2), 528-532, 2022 | 43 | 2022 |
| Efficacy of BRAF‐Inhibitor Therapy in BRAFV600E‐Mutated Adult Langerhans Cell Histiocytosis AZ Hazim, GJ Ruan, A Ravindran, JP Abeykoon, C Scheckel, R Vassallo, ... The Oncologist 25 (12), 1001-1004, 2020 | 42 | 2020 |
| Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients M Li, M Binder, T Lasho, A Ferrer, N Gangat, A Al-Kali, A Mangaonkar, ... Blood Advances 5 (8), 2272-2278, 2021 | 38 | 2021 |
Hassan AlkhateebMayo ClinicVerified email at mayo.edu